Convergence: Understanding expedited approval pathways in Japan
Regulatory NewsMary Ellen Schneider
AsiaBiologics/ biosimilars/ vaccinesPharmaceuticalsResearch, Design and DevelopmentRegulatory NewsMary Ellen SchneiderAsiaBiologics/ biosimilars/ vaccinesPharmaceuticalsResearch, Design and Development